Metraipolis › archive › dc_77c5a89cb05f

Targeting reactivated toxoplasmosis: therapeutic efficacy of the green-synthesized copper nanoparticles combined with pyrimethamine — Europe PMC PMID:42240336

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42240336
DOI
10.1128/aac.00019-26
License (as archived)
solo-consultazione
Archived
2026-10-31T19:52:37.326Z
SHA-256 of the archived text
9077c813fe391adea25963d529ba8406cc988ae965f0dc2ceea011d53c6c0fd5
Stable URL of this page
https://metraipolis.com/documento/dc_77c5a89cb05f

How to cite

Targeting reactivated toxoplasmosis: therapeutic efficacy of the green-synthesized copper nanoparticles combined with pyrimethamine — Europe PMC PMID:42240336 — Europe PMC (en), https://europepmc.org/article/MED/42240336 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_77c5a89cb05f (Metraipolis archive dc_77c5a89cb05f, sha256 9077c813fe391adea25963d529ba8406cc988ae965f0dc2ceea011d53c6c0fd5)
BibTeX
@misc{dc77c5a89cb05f,
  title = {Targeting reactivated toxoplasmosis: therapeutic efficacy of the green-synthesized copper nanoparticles combined with pyrimethamine — Europe PMC PMID:42240336},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42240336},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_77c5a89cb05f; sha256 9077c813fe391adea25963d529ba8406cc988ae965f0dc2ceea011d53c6c0fd5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42240336. Agents can read the archived copy with the MCP tool read_document.